Urothelial Carcinoma clinical trials

Explore recruiting urothelial carcinoma clinical trials.

Recruiting urothelial carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Urothelial Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Clofarabine Therapy in Patients with Locally Advanced or Metastatic Urothelial Carcinoma: a Phase 1/2 Dose-Escalation Study

Austria

Phase I and Phase II (Integrated)- Other EU CTIS Study details

An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants from Multiple Avelumab (MSB0010718C) Clinical Studies

Italy, Bulgaria, Poland, Romania, France, Spain +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective randomised study of the impact of preoperative administration of mitomycin-C by electromotive drug administration (EMDA) in patients with non-muscle invasive urothelial carcinoma

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 2, Open-Label, Randomized Study of Livmoniplimab in Combination with Budigalimab Versus Chemotherapy in Subjects with Metastatic Urothelial Carcinoma

Poland, Spain, France, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Multicenter clinical trial with medical device associated with a drug in an authorised therapeutic use for the treatment of CVNMI evaluating the efficacy and tolerability of the adyuvant treatment with EMDA-MMC versus standard BCG in patients with high grade CVNMI

Spain

Therapeutic use (Phase IV) EU CTIS Study details

C5731002 - A Phase 2 Multi-Cohort, Open-Label, Multi-Center Clinical Study Evaluating the Efficacy and Safety of Disitamab Vedotin (RC48-ADC) Alone or in Combination with Pembrolizumab in Subjects with Locally-Advanced Unresectable or Metastatic Urothelial Carcinoma That Expresses HER2

Belgium, Spain, France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Urothelial Carcinoma trials by city

Urothelial Carcinoma in Toronto Urothelial Carcinoma in Vancouver Urothelial Carcinoma in Montreal Urothelial Carcinoma in Calgary Urothelial Carcinoma in Edmonton Urothelial Carcinoma in Ottawa Urothelial Carcinoma in Winnipeg Urothelial Carcinoma in Quebec City Urothelial Carcinoma in Hamilton Urothelial Carcinoma in Kitchener Urothelial Carcinoma in London Urothelial Carcinoma in Halifax Urothelial Carcinoma in New York Urothelial Carcinoma in Los Angeles Urothelial Carcinoma in Chicago Urothelial Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease